Quantcast
Last updated on April 24, 2014 at 6:39 EDT

Latest Clinical research Stories

2014-03-26 08:30:18

-- Multi-Year Signings for Enterprise-wide Technology and Support -- NEWTOWN, Pa., March 26, 2014 /PRNewswire/ -- BioClinica®, Inc., a leading provider of specialized outsourced clinical trial services, today announced that it recently penned $30 million in multi-year contract renewals with two major pharmaceutical companies. Collectively these engagements encompass cloud-based technologies and professional services and training across BioClinica's full eClinical product suite:...

2014-03-26 08:30:13

ALISO VIEJO, Calif., March 26, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application (NDA) of AVP-825, its innovative Breath Powered(TM) investigational drug-device combination product for the acute treatment of migraine. http://photos.prnewswire.com/prnvar/20130207/LA55901LOGO As previously reported the company's 505(b)(2) NDA for AVP-825 includes data from...

2014-03-25 23:32:12

The globally standardized certification methodology is now accepted across healthcare organizations, clinical trial sponsors, CROs and regulatory agencies. Austin, TX (PRWEB) March 25, 2014 More than 500,000 healthcare and clinical research professionals in 164 countries representing every continent have been trained and certified on the NIH Stroke Scale (NIHSS) and can now share their standardized certifications electronically across employees, sponsors and clinical trials via HCP’s...

2014-03-25 23:21:59

New patient recruiting and retention eBook features marketing, social media, education, planning, communication, and other tips and strategies from leading clinical trials experts. San Francisco, CA (PRWEB) March 25, 2014 Mosio, an award-winning mobile software company providing solutions in clinical research, health services and other industries, announces the release of its new “Clinical Trials Patient Recruiting and Retention: Tips for Success” eBook. The company has partnered with...

2014-03-25 23:04:58

Global regulators, industry professionals and academia will gather at the event in Miami, Florida from May 14 to 15 to discuss the current regulatory landscape, future research and drug development in Latin America. Washington, DC (PRWEB) March 25, 2014 Twelve regulatory authorities from around the world will be among attendees discussing the opportunities provided by collaborating to achieve harmonization in regulation at the Latin American Regulatory Conference (LARC) 2014. Global...

2014-03-25 16:26:21

SD-560 is a Novel Oral Small Molecule for the Potential Treatment of Idiopathic Pulmonary Fibrosis and Other Fibrotic Conditions LA JOLLA, Calif., March 25, 2014 /PRNewswire/ -- Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, today announced the issuance of the following composition of matter and method of treatment patents covering its...

2014-03-25 16:25:48

Panel's Expertise Will Guide Funding Priorities and Community Engagement WASHINGTON, March 25, 2014 /PRNewswire-USNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved 13 people as members of PCORI's new Advisory Panel on Rare Disease. It is one of two new advisory panels for which the Board approved members at its meeting today; the other focuses on clinical trials. The diverse group of panelists will apply their experience and...

2014-03-25 16:25:46

Panel Will Provide Expertise on Trial Selection, Design and Implementation WASHINGTON, March 25, 2014 /PRNewswire-USNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today appointed 10 people as members of PCORI's new Advisory Panel on Clinical Trials. It is one of two new advisory panels whose members the Board approved at its meeting today; the other focuses on rare disease. Members of the Advisory Panel on Clinical Trials will support...

2014-03-25 08:29:23

CALGARY, March 25, 2014 /CNW/ - Kevin Kuykendall, Chief Executive Officer of Vivione Biosciences Inc. ("Vivione" or the "Company") (TSXV: VBI) was recently interviewed by Lynn Fosse, Senior Editor of CEOCFO Magazine in response to the Company's developmental successes in the commercialization of the RAPID B platform over the past year. For the full article and additional details, please visit www.vivonebiosciences.com. Delivering on the key theme of Vivione as an early stage...

2014-03-25 08:29:07

REDWOOD CITY, Calif., March 25, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced the appointment of Timothy E. Morris as chief financial officer (CFO). Mr. Morris brings 30 years of professional finance and accounting experience to AcelRx, 18 of those years spent in the role of chief financial...